Diadema Partners’s Replimune Group REPL Stock Holding History

Diadema Partners’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Buy	502,500 +42,600	+9%	+$261K	0.7%	43
2026 Q1	$3.52M	Buy	+459,900	New	+$3.52M	0.6%	45

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Diadema Partners's REPL Position: Q2 2026 in Review

Diadema Partners sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 100,660 shares — an estimated $616K sold.

Diadema Partners first reported a position in REPL in Q4 2024 and held it in 5 quarters. The position peaked at $2.25M in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

Diadema Partners reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
Diadema Partners sold 100,660 Replimune Group shares in Q2 2026, an estimated $616K.
Diadema Partners first reported a position in Replimune Group in Q4 2024 and held it in 5 quarters.
Diadema Partners's Replimune Group position peaked at $2.25M in Q4 2025.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.